Covalent organic frameworks (COFs) with well-defined and customizable pore structures are promising templates for the synthesis of nanomaterials with controllable sizes and dispersity. Herein, a thioether-containing COF has been rationally designed and used for the confined growth of ultrafine metal nanoparticles (NPs). Pt or Pd nanoparticles (Pt NPs and Pd NPs) immobilized inside the cavity of the COF material have been successfully prepared at a high loading with a narrow size distribution (1.7 ± 0.2 nm). We found the crystallinity of the COF support and the presence of thioether groups inside the cavities are critical for the size-controlled synthesis of ultrafine NPs. The as-prepared COF-supported ultrafine Pt NPs and Pd NPs show excellent catalytic activity respectively in nitrophenol reduction and Suzuki-Miyaura coupling reaction under mild conditions and low catalyst loading. More importantly, they are highly stable and easily recycled and reused without loss of their catalytic activities. Such COF-supported size-controlled synthesis of nanoparticles will open a new frontier on design and preparation of metal NP@COF composite materials for various potential applications, such as catalysis and development of optical and electronic materials.
Ionic covalent organic frameworks
(ICOFs) have recently emerged
as promising candidates for solid-state electrolytes. Herein, we report
the first example of a series of crystalline imidazolate-containing
ICOFs as single-ion conducting COF solid electrolyte materials, where
lithium cations freely travel through the intrinsic channels with
outstanding ion conductivity (up to 7.2 × 10–3 S cm–1) and impressively low activation energy
(as low as 0.10 eV). These properties are attributed to the weak Li
ion–imidazolate binding interactions and well-defined porous
2D framework structures of such ICOFs. We also investigated the structure–property
relationship by varying the electronic properties of substituents
(electron donating/withdrawing) that covalently attached to the imidazolate
groups. We found electron-withdrawing substituents significantly improve
the ion-conducting ability of imidazolate-ICOF by weakening ion-pair
interactions. Our study provides a convenient bottom-up approach toward
a novel class of highly efficient single-ion conducting ICOFs which
could be used in all solid-state electrolytic devices.
High-entropy alloys have received considerable attention in the field of catalysis due to their exceptional properties. However, few studies hitherto focus on the origin of their outstanding performance and the accurate identification of active centers. Herein, we report a conceptual and experimental approach to overcome the limitations of single-element catalysts by designing a FeCoNiXRu (X: Cu, Cr, and Mn) High-entropy alloys system with various active sites that have different adsorption capacities for multiple intermediates. The electronegativity differences between mixed elements in HEA induce significant charge redistribution and create highly active Co and Ru sites with optimized energy barriers for simultaneously stabilizing OH* and H* intermediates, which greatly enhances the efficiency of water dissociation in alkaline conditions. This work provides an in-depth understanding of the interactions between specific active sites and intermediates, which opens up a fascinating direction for breaking scaling relation issues for multistep reactions.
Circulating Tfr cells are increased as patients with RA achieve stable remission of disease, and increased Tfr cells can suppress autoimmunity in RA patients to stabilize their condition. Our results provide novel insight into RA pathogenesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.